The DOI matches its Crossref record.
HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12
Abstract
KEERTI SHAH, NEAL NATHANSON; HUMAN EXPOSURE TO SV40: REVIEW AND COMMENT12, American Journal of Epidemiology, Volume 103, Issue 1, 1 January 1976, Pages 1–12, ht
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This included the contamination of poliovirus vaccine with Simian Virus 40 (SV40) 3 , for which the health impacts were not fully known for many decades 4 .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [3]
In the citing paper
“In the 20 th century several vaccine products were unintentionally contaminated with unwanted viruses during their production [1][2][3] .”
From Viral contamination in biologic manufacture and implications for emerging therapies (2020) · cites this paper as [3]
Citations
Cites
Still being checked.
Cited by
Sorted by citations
Items 101–200 of 339
Weiss, R. A. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-55541-1_3 · Cited by 35
Xie, Y., Hwang, C., Overwijk, W. W., Zeng, Z., Eng, M. H., Mulé, J. J., Imperiale, M. J., Restifo, N. P., & Sanda, M. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.169 · Cited by 35
Lednicky, J. A., & Butel, J. S. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0345 · Cited by 35
Patterns of polyomavirus SV40 infections and associated cancers in humans: a model
Butel, J. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.06.004 · Cited by 34
Examination of Poliovirus Vaccine Preparations for SV40 Sequences
Sangar, D. V., Pipkin, P. A., Wood, D. J., & Minor, P. D. (1999) · Biologicals · doi:10.1006/biol.1998.0170 · Cited by 34
Viruses in glioblastoma: an update on evidence and clinical trials
Gunasegaran, B., Ashley, C. L., Marsh‐Wakefield, F., Guillemin, G. J., & Heng, B. (2024) · BJC Reports · doi:10.1038/s44276-024-00051-z · Cited by 32
Simian virus 40 and human pleural mesothelioma
Mulatero, C., Surentheran, T., Breuer, J., & Rudd, R. (1999) · Thorax · doi:10.1136/thx.54.1.60 · Cited by 32
Woloschak, M., Yu, A., & Post, K. D. (1995) · Cancer · doi:10.1002/1097-0142(19950801)76:3 · Cited by 30
Failure to demonstrate papovavirus tumor antigen in human cerebral neoplasms
Greenlee, J., Becker, L. E., Narayan, O., & Johnson, R. T. (1978) · Annals of Neurology · doi:10.1002/ana.410030604 · Cited by 30
The burden of proof and the origin of acquired immune deficiency syndrome
Martin, B. G. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0868 · Cited by 29
Natural and iatrogenic factors in human immunodeficiency virus transmission
Weiss, R. A. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0870 · Cited by 29
Butel, J. S. (2000) · Europe PMC (PubMed Central) · Cited by 28
Völter, C., Hausen, H. Z., Alber, D., & de Villiers, E. (1997) · Virology · doi:10.1006/viro.1997.8772 · Cited by 28
Klug, B., Robertson, J. S., CONDIT, R. C., Seligman, S. J., Laderoute, M. P., Sheets, R., Williamson, A., Gurwith, M., Kochhar, S., Chapman, L. E., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.015 · Cited by 27
Engels, E. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh219 · Cited by 27
Disinformation squared: Was the HIV-from-Fort-Detrick myth a Stasi success?
Geißler, E., & Sprinkle, R. H. (2013) · Politics and the Life Sciences · doi:10.2990/32_2_2 · Cited by 26
Tognon, M. G., Corallini, A., Manfrini, M., Taronna, A., Butel, J. S., Pietrobon, S., Trevisiol, L., Bononi, I., Vaccher, E., Barbanti‐Brodano, G., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145720 · Cited by 26
Asbestos, Simian virus 40 and malignant mesothelioma
Stenton, S. (1997) · Thorax · doi:10.1136/thx.52.2008.s52 · Cited by 26
SV40 large T-antigen and human pleural mesothelioma
Dhaene, K., Verhulst, A., & Marck, E. V. (1999) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050387 · Cited by 26
Developments in the production and quality control of poliovirus vaccines – Historical perspectives
Furesz, J. (2006) · Biologicals · doi:10.1016/j.biologicals.2006.02.008 · Cited by 25
Review on the Relationship between Human Polyomaviruses-Associated Tumors and Host Immune System
Delbue, S., Comar, M., & Ferrante, P. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/542092 · Cited by 25
Engels, E. A. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.197 · Cited by 25
The aetiology of mesothelioma: are risk factors other than asbestos exposure important?
Hubbard, R. (1997) · Thorax · doi:10.1136/thx.52.6.496 · Cited by 25
Polio vaccines and the origin of AIDS
Elswood, B. F., & Stricker, R. B. (1994) · Medical Hypotheses · doi:10.1016/0306-9877(94)90151-1 · Cited by 25
Spontaneous and experimental malignancies in non‐human primates
Lapin, B. A., & Yakovleva, L. A. (2014) · Journal of Medical Primatology · doi:10.1111/jmp.12098 · Cited by 24
Toscano, M. G., & de Haan, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01160 · Cited by 24
Maternal human polyomavirus infection and risk of neuroblastoma in the child
Stolt, A., Kjellin, M., Sasnauskas, K., Luostarinen, T., Koskela, P. U., Lehtinen, M., & Dillner, J. (2004) · International Journal of Cancer · doi:10.1002/ijc.20573 · Cited by 24
Simian Virus 40 and Human Disease
Shah, K. V. (2004) · The Journal of Infectious Diseases · doi:10.1086/425999 · Cited by 24
Self-citationGurney, J. G., Smith, M. A., Olshan, A. F., Hecht, S. S., & Kasum, C. M. (2001) · Cancer Investigation · doi:10.1081/cnv-100104291 · Cited by 23
Minor, P. D. (1994) · Trends in biotechnology · doi:10.1016/0167-7799(94)90136-8 · Cited by 23
Lewis, A. M., & Cook, J. L. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2886 · Cited by 23
Polyomaviruses detectable in head and neck carcinomas
Poluschkin, L., Rautava, J., Turunen, A., Wang, Y., Hedman, K., Syrjänen, K. J., Grenman, R. A., & Syrjänen, S. (2018) · Oncotarget · doi:10.18632/oncotarget.25202 · Cited by 22
Sutter, R. W., Kew, O. M., Cochi, S. L., & Aylward, R. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00048-1 · Cited by 22
Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40
Leithner, K., Leithner, A., Clar, H., Weinhaeusel, A., Radl, R., Krippl, P., Rehak, P., Windhager, R. H., Haas, O. A., & Olschewski, H. (2006) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-1-44 · Cited by 22
Scientific Controversy and Asbestos: Making Disease Invisible
Braun, L., Greene, A., Manseau, M. W., Singhal, R., Kisling, S., & Jacobs, N. J. (2003) · International Journal of Occupational and Environmental Health · doi:10.1179/oeh.2003.9.3.194 · Cited by 22
Absence of SV40 in Austrian Tumors Correlates with Low Incidence of Mesotheliomas
Leithner, A., Weinhaeusel, A., Windhager, R. H., Schlegl, R., Waldner, P., Lang, S., Dominkus, M., Zoubek, A., Popper, H., & Haas, O. A. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.4.10 · Cited by 22
Nahmias, A. J., & Reanney, D. C. (1977) · Annual Review of Ecology and Systematics · doi:10.1146/annurev.es.08.110177.000333 · Cited by 22
Schell, T. D., Lippolis, J. D., & Tevethia, S. S. (2001) · PubMed · Cited by 22
Molecular Identification of Simian Virus 40 Infection in Healthy Italian Subjects by Birth Cohort
Paracchini, V., GARTE, S. J., Pedotti, P., Poli, F., Frison, S., & Taioli, E. (2005) · Molecular Medicine · doi:10.2119/2005-00007.taioli · Cited by 21
Failure to confirm presence of SV40 sequences in human tumours
Krainer, M., Schenk, T., Zielinski, C., & Müller, C. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(95)00284-p · Cited by 21
No evidence for simian virus 40 DNA sequences in malignant non-Hodgkin lymphomas
Schüler, F., Dölken, S., Hirt, C., Dölken, M. T., Mentel, R., Gürtler, L. G., & Dölken, G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21346 · Cited by 19
Kidney, B. A., Haines, D. M., Ellis, J. A., Burnham, M. L., & Jackson, M. L. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.828 · Cited by 19
Engels, E. A., Rodman, L. H., Frisch, M., Goedert, J. J., & Biggar, R. J. (2003) · International Journal of Cancer · doi:10.1002/ijc.11211 · Cited by 19
Association of BK and JC Human Polyomaviruses and SV40 with Human Tumors
Monini, P., Lellis, L. D., & Barbanti‐Brodano, G. (1995) · Infectious agents and pathogenesis · doi:10.1007/978-1-4899-1100-1_4 · Cited by 19
Evaluation of SV40 in osteosarcoma and healthy population: A Hungarian-German study
Heinsohn, S. (1994) · Oncology Reports · doi:10.3892/or_00000220 · Cited by 18
Identification of a novel polyomavirus from vervet monkeys in Zambia
Yamaguchi, H., Kobayashi, S., Ishii, A., Ogawa, H., Nakamura, I., Moonga, L., Hang’ombe, B. M., Mweene, A. S., Thomas, Y., Kimura, T., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.050740-0 · Cited by 18
Jin, M., Sawa, H., Suzuki, T., Shimizu, K., Makino, Y., Tanaka, S., Nojima, T., Fujioka, Y., Asamoto, M., Suko, N., et al. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20219 · Cited by 18
Ziegler, A., Seemayer, C. A., Hinterberger, M., VOGT, P. R., Bigosch, C., Gautschi, O. P., Tornillo, L., Betticher, D. C., Moch, H., & Stahel, R. A. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.03.025 · Cited by 18
Martin, J. D. (1989) · Virus Research · doi:10.1016/0168-1702(89)90072-5 · Cited by 18
Stricker, R. B., & Goldberg, B. (2001) · The Lancet · doi:10.1016/s0140-6736(05)71577-4 · Cited by 18
The RB2/p130 gene: the latest weapon in the war against lung cancer?
Claudio, P. P., Caputi, M., & Giordano, A. (2000) · PubMed · Cited by 18
Papovaviridae: The Polyomaviruses
Arthur, R. R., & Shah, K. V. (1988) · Springer eBooks · doi:10.1007/978-1-4612-3900-0_17 · Cited by 18
Self-citationNatural infection and transmission of SV40
Minor, P. D., Pipkin, P. A., Cutler, K., & Dunn, G. (2003) · Virology · doi:10.1016/s0042-6822(03)00435-5 · Cited by 17
Richmond, J. E., Parry, J. V., & Gardner, S. D. (1984) · Archives of Virology · doi:10.1007/bf01310654 · Cited by 17
Neurologic Tumors in Offspring after Inoculation of Mothers with Killed-Poliovirus Vaccine
von Wussow, P., Freund, M., Dahle, S., Jakschies, D., Poliwode, H., & Deicher, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811033191815 · Cited by 17
Urine-based diagnostic technologies
Urnovitz, H. B., Murphy, W. H., Gottfried, T. D., & Friedman‐Kien, A. E. (1996) · Trends in biotechnology · doi:10.1016/0167-7799(96)10048-2 · Cited by 16
Xenograft Transplantation and the Infectious Disease Conundrum
Allan, J. (1995) · ILAR Journal · doi:10.1093/ilar.37.1.37 · Cited by 16
Viruses and Hodgkin lymphoma: No evidence of polyomavirus genomes in tumor biopsies
Wilson, K. S., Gallagher, A., Freeland, J. M. L., Shield, L. A., & Jarrett, R. F. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500525789 · Cited by 16
Nuclear factor of activated T-cells (NFAT) plays a role in SV40 infection
Manley, K., O’Hara, B. A., & Atwood, W. J. (2007) · Virology · doi:10.1016/j.virol.2007.10.029 · Cited by 19
Lednicky, J. A., & Butel, J. S. (1997) · Journal of Virological Methods · doi:10.1016/s0166-0934(96)02135-0 · Cited by 16
A multivalent polyomavirus vaccine elicits durable neutralizing antibody responses in macaques
Peretti, A., Scorpio, D. G., Kong, W., Pang, Y.-Y. S., McCarthy, M. P., Ren, K., Jackson, M., Graham, B. S., Buck, C. B., McTamney, P. M., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.02.002 · Cited by 15
SV40 association with human malignancies and mechanisms of tumor immunity by large tumor antigen
Lowe, D. B., Shearer, M. H., Jumper, C., & Kennedy, R. C. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6414-6 · Cited by 15
Effective Gene Transfer Using Viral Vectors Based on SV40
Strayer, D. S. (2003) · Humana Press eBooks · doi:10.1385/1-59259-215-5:61 · Cited by 15
Rollison, D. E. M., Helzlsouer, K. J., Halsey, N. A., Shah, K. V., & Viscidi, R. P. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0674 · Cited by 14
Self-citationPeden, K., Li, S., Omeir, R. L., Yacobucci, M., Klutch, M. J., Laassri, M., Chumakov, K., Pal, A., Murata, H., & Lewis, A. M. (2007) · Virology · doi:10.1016/j.virol.2007.06.045 · Cited by 14
Increasing Evidence for Involvement of SV40 in Human Cancer
Butel, J. S. (2001) · Disease Markers · doi:10.1155/2001/857621 · Cited by 14
Contamination of poliovirus vaccine with SV40 and the incidence of medulloblastoma
Strickler, H. D., Rosenberg, P. S., Devesa, S. S., Fraumeni, J. F., & Goedert, J. J. (1999) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(199901)32:1 · Cited by 14
Low incidence of SV40‐like sequences in ependymal tumours
Reuther, F., Löhler, J., Herms, J. W., Hugo, H. ‐., Schindler, C., Leithäuser, F., Melzner, I., Möller, P., & Scheil, S. (2001) · The Journal of Pathology · doi:10.1002/path.1005 · Cited by 14
Engels, E. A. (2005) · Cancer Investigation · doi:10.1080/07357900500202820 · Cited by 13
Polyomavirus SV40 infections in Kazakhstan
Nurgalieva, Z. Z., Wong, C. C., Zhangabylov, A. K., Omarbekova, Z. E., Graham, D. Y., Vilchez, R. A., & Butel, J. S. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.03.001 · Cited by 13
Association Between SV40 and Non-Hodgkin's Lymphoma
Butel, J. S., Vilchez, R. A., Jorgensen, J. L., & Kozinetz, C. A. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001623784 · Cited by 13
STUDIES OF CULTURED HUMAN AND SIMIAN FETAL BRAIN CELLS
Oster‐Granite, M. L., Narayan, O., Johnson, R. T., & Herndon, R. M. (1978) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1978.tb01355.x · Cited by 13
Bofill-Mas, S., Albiñana-Giménez, N., Pipkin, P. A., Minor, P. D., & Gironés, R. (2004) · Virology · doi:10.1016/j.virol.2004.09.007 · Cited by 13
Adventitious Viral Genomes in Vaccines but Not in Vaccinees
Weiss, R. A. (2001) · Emerging infectious diseases · doi:10.3201/eid0701.010124 · Cited by 13
Influence of the Viral Regulatory Region on Tumor Induction by Simian Virus 40 in Hamsters
Šroller, V., Vilchez, R. A., Stewart, A. R., Wong, C. C., & Butel, J. S. (2007) · Journal of Virology · doi:10.1128/jvi.01626-07 · Cited by 13
Rosa, F. W., Sever, J. L., & Madden, D. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806023182216 · Cited by 13
The WetNet: What the Oral Polio Vaccine Hypothesis Exposes about Globalized Interspecies Fluid Bonds
Jain, S. L. (2020) · Medical Anthropology Quarterly · doi:10.1111/maq.12587 · Cited by 14
Polyomavirus SV40: Model Infectious Agent of Cancer
Butel, J. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0016-5_15 · Cited by 12
O’Neill, F. J., Greenlee, J., & Carney, H. (2003) · Virology · doi:10.1016/s0042-6822(03)00116-8 · Cited by 12
Activation of simian virus 40 promoter by HTLV-I Tax protein: role of NF-$kappa;B and CBP
Tabakin-Fix, Y., Huleihel, M., & Aboud, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.137 · Cited by 12
McLaren, B. R., Haenel, T., Stevenson, S., Mukherjee, S., Robinson, B. W. S., & Lake, R. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb02050.x · Cited by 12
Polyoma Viruses (JC Virus, BK Virus, and Simian Virus 40) and Human Cancer
Shah, K. V. (2000) · doi:10.1007/978-1-59259-024-7_26 · Cited by 12
Self-citationCell Culture-Derived Influenza Vaccines
Dormitzer, P. R. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0279-2_12 · Cited by 11
Tight Junction Proteins and Cancer
Latorre, I., Frese, K., & Javier, R. (2006) · Springer eBooks · doi:10.1007/0-387-36673-3_9 · Cited by 15
Ethnic differences in polyomavirus simian virus 40 seroprevalence among women in Houston, Texas
Wong, C. C., Vilchez, R. A., Quiroz, J., Adam, E., & Butel, J. S. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.08.014 · Cited by 11
No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden.
Lundstig, A., Dejmek, A., Eklund, C., Filinic, I., & Dillner, J. (2007) · PubMed · Cited by 11
Neutralizing and IgG Antibodies against Simian Virus 40 in Healthy Pregnant Women in Italy
Comar, M., Wong, C. C., Tognon, M. G., & Butel, J. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110700 · Cited by 11
Evolution of Approaches to Viral Safety Issues for Biological Products
Lubiniecki, A. S. (2011) · PDA Journal of Pharmaceutical Science and Technology · doi:10.5731/pdajpst.2011.00818 · Cited by 11
Dalyot-Herman, N., Rund, D. G., & Oppenheim, A. (1999) · Stem Cells and Development · doi:10.1089/152581699319759 · Cited by 11
Causality of mesothelioma: SV40 question
Shah, K. V. (2004) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/s1547-4127(04)00112-4 · Cited by 11
Self-citationPeer Review and the Origin of AIDS: A Case Study in Rejected Ideas
Martin, B. G. (1993) · BioScience · doi:10.2307/1312149 · Cited by 11
Absence of simian virus 40 (SV40) DNA in lymphoma samples from Tasmania, Australia
Sui, L.-F., Williamson, J., Lowenthal, R. M., & Parker, A. J. C. (2005) · Pathology · doi:10.1080/00313020500058474 · Cited by 11
SV40-Immortalized Human Fibroblasts as a Source of SV40 Infectious Virions
Morelli, M. C., Barbisan, F., Iaccheri, L., & Tognon, M. G. (2004) · Molecular Medicine · doi:10.2119/2004-00037.morelli · Cited by 10
Stark, L., & CAMPBELL, N. D. (2014) · Studies in History and Philosophy of Science Part C Studies in History and Philosophy of Biological and Biomedical Sciences · doi:10.1016/j.shpsc.2014.07.011 · Cited by 10
Extraneous agent detection in vaccines − A review of technical aspects
Farsang, A., & Kulcsár, G. (2012) · Biologicals · doi:10.1016/j.biologicals.2012.04.004 · Cited by 10
Chen, P., Yen, C., Yang, M., Poh, S.-B., Hsiao, L., Wang, W.-S., Lin, P., Lee, M.-Y., Teng, H., Bai, L.-Y., et al. (2006) · Cancer Investigation · doi:10.1080/07357900600629609 · Cited by 10
Reappraisal of progressive multifocal leukoencephalopathy due to simian virus 40
Stoner, G. L., & Ryschkewitsch, C. F. (1998) · Acta Neuropathologica · doi:10.1007/s004010050894 · Cited by 10
Martin, J. D., & Li, P. (1991) · Virus Research · doi:10.1016/0168-1702(91)90043-u · Cited by 10
The immunopathology of SV40-induced transformation
Mora, P. T. (1982) · Springer Seminars in Immunopathology · doi:10.1007/bf00201954 · Cited by 10
Simian virus 40 and mesothelioma in Great Britain
Price, M. J., Darnton, A., McElvenny, D. M., & Hodgson, J. T. (2007) · Occupational Medicine · doi:10.1093/occmed/kqm079 · Cited by 9
Metadata
- Authors
- SHAH, K., & NATHANSON, N.
- Corresponding author
- SHAH, KEERTI
- ORCID
- NATHANSON, NEAL
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1976-01
- Volume
- 103
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W2158307330
- Cited by
- 339
- References
- 0
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 22 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 9 · 2013: 8 · 2012: 12
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Polyomavirus and related diseases
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Keywords
- simian virus 40, human exposure, viral oncogenesis, retroviruses
- MeSH terms
- Adult, Aged, Animals, Antibodies, Viral, Antigens, Neoplasm, Child, Disease Reservoirs, Female, Follow-Up Studies, Humans, Immunization, Infant, Newborn, Leukoencephalopathy, Progressive Multifocal, Middle Aged, Neoplasms, Oncogenic Viruses, Poliovirus Vaccine, Inactivated, Population Surveillance, Pregnancy, Prospective Studies, Retrospective Studies, Simian virus 40, Virus Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review